What's new

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised

Feb 20, 2025 - 10:22
 0
Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

HBX Group and Minor Hotels expand strategic partnership to include hotels in Aus...

Next Article

Switzerland’s Haelixa appoints Marwa Zamaray to advisory board

Related Posts

Fifth EMA/HMA Big Data Stakeholder Forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 November 2024, 09:30 (CET) to 28 November 2024, 17:30 (CET)

Fifth EMA/HMA Big Data Stakeholder Forum, Online, Europ...

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

List of centrally authorised products with safety-relat...

Feb 28, 2025  0